Endothelial Cell Density and Central Corneal Thickness following Penetrating Keratoplasty of Acanthamoeba Keratitis Patients – A Retrospective Cross-Sectional Observational Study

Abstract Purpose To analyze endothelial cell density (ECD) and central corneal thickness (CCT) following penetrating keratoplasty (PKP) in Acanthamoeba keratitis (AK) patients. Patients and Methods In this retrospective, clinical, single-center, cross-sectional, observational study, patients were enrolled who underwent PKP at the Department of Ophthalmology of Saarland University Medical Center, Homburg/Saar, Germany between May 2008 and December 2016 with the diagnosis of AK. In all, 33 eyes of 33 patients (14 males, 42%) were enrolled; their mean age at the time of surgery was 39.5 ± 14.3 years. Postoperatively, AK patients received topical polyhexamethylene biguanide, propamidine isethionate, neomycin sulphate/gramicidin/polymixin B sulfate, and prednisolone acetate eye drops (5 ×/day each), and the topical treatment was tapered sequentially with 1 drop every 6 weeks over 6 months. CCT was recorded using Pentacam HR Scheimpflug tomography and ECD with the EM-3000 specular microscope before surgery and 3 and 6 months after surgery as well as after the first and second (complete) suture removal. Results ECD tended to decrease significantly from the time point before surgery (2232 ± 296 cells/mm2) to the time point 3 months after surgery (1914 ± 164 cells/mm2; p = 0.080) and to the time point after the first suture removal (1886 ± 557 cells/mm2; p = 0.066) and decrease significantly to the time point after the second suture removal (1650 ± 446 cells/mm2; p = 0.028). CCT did not change significantly over the analyzed time period (p ≥ 0.475). Conclusion In AK, endothelial cell loss does not seem to be accelerated following PKP, despite the postoperative use of diamidine and biguanide. A subsequent prospective comparative study should confirm our retrospective longitudinal analysis.

[1]  B. Seitz,et al.  Early Penetrating Keratoplasty À Chaud May Improve Outcome in Therapy-Resistant Acanthamoeba Keratitis , 2019, Advances in Therapy.

[2]  B. Seitz,et al.  Endothelial cell density and corneal graft thickness following excimer laser vs. femtosecond laser-assisted penetrating keratoplasty—a prospective randomized study , 2019, Graefe's Archive for Clinical and Experimental Ophthalmology.

[3]  B. Seitz,et al.  Reactive uveitis, retinal vasculitis and scleritis as ocular end-stage of acanthamoeba keratitis - a histological study , 2018 .

[4]  B. Seitz,et al.  Acanthamoeba keratitis – Clinical signs, differential diagnosis and treatment , 2018, Journal of current ophthalmology.

[5]  J. Hjortdal,et al.  Outcome of Human Donor Corneas Stored for More Than 4 Weeks , 2018, Cornea.

[6]  B. Seitz,et al.  The Effect of Antiamoebic Agents on Viability, Proliferation and Migration of Human Epithelial Cells, Keratocytes and Endothelial Cells, In Vitro , 2018, Current eye research.

[7]  B. Seitz,et al.  Reconsidering Sequential Double Running Suture Removal After Penetrating Keratoplasty: A Prospective Randomized Study Comparing Excimer Laser and Motor Trephination , 2017, Cornea.

[8]  Shiyou Zhou,et al.  Associated factors, diagnosis and management of Acanthamoeba keratitis in a referral Center in Southern China , 2017, BMC Ophthalmology.

[9]  B. Seitz,et al.  [Functional Results and Graft Failure after Repeat Keratoplasty]. , 2017, Klinische Monatsblätter für Augenheilkunde.

[10]  W. Pawłowski,et al.  Emerging Threats for Human Health in Poland: Pathogenic Isolates from Drug Resistant Acanthamoeba Keratitis Monitored in terms of Their In Vitro Dynamics and Temperature Adaptability , 2015, BioMed research international.

[11]  J. Lorenzo-Morales,et al.  An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment , 2015, Parasite.

[12]  Yang Gao,et al.  Clinical outcomes of non-torque pattern double running suture technique for optical penetrating keratoplasty. , 2015, International journal of clinical and experimental medicine.

[13]  B. Seitz,et al.  Crosslinking and corneal cryotherapy in acanthamoeba keratitis — a histological study , 2015, Graefe's Archive for Clinical and Experimental Ophthalmology.

[14]  Y. Iwatani,et al.  In vitro evaluations of topical agents to treat Acanthamoeba keratitis. , 2014, Ophthalmology.

[15]  J. Walochnik,et al.  Miltefosine and polyhexamethylene biguanide: a new drug combination for the treatment of Acanthamoeba keratitis , 2014, Clinical & experimental ophthalmology.

[16]  A. M. Chudzinski-Tavassi,et al.  Antimicrobial action of biguanides on the viability of Acanthamoeba cysts and assessment of cell toxicity. , 2013, Investigative ophthalmology & visual science.

[17]  K. Sugiyama,et al.  In vivo laser confocal microscopy findings of radial keratoneuritis in patients with early stage Acanthamoeba keratitis. , 2013, Ophthalmology.

[18]  J. Shimazaki,et al.  Ocular Surface Reconstruction After Exposure to High Concentrations of Antiseptic Solutions , 2012, Cornea.

[19]  Cui Li,et al.  Effect of corneal graft diameter on therapeutic penetrating keratoplasty for fungal keratitis. , 2012, International journal of ophthalmology.

[20]  C. McGhee,et al.  The New Zealand National Eye Bank: Survival and Visual Outcome 1 Year After Penetrating Keratoplasty , 2011, Cornea.

[21]  稗田 牧,et al.  Descemet's Stripping Automated Endothelial Keratoplasty 術後における角膜内皮細胞密度の変化と影響因子の検討 , 2011 .

[22]  S. Debanne,et al.  Descemet's stripping automated endothelial keratoplasty outcomes compared with penetrating keratoplasty from the Cornea Donor Study. , 2010, Ophthalmology.

[23]  S. Guerriero,et al.  A Case of Descemet's Membrane Rupture in a Patient Affected by Acanthamoeba Keratitis , 2009, Eye & contact lens.

[24]  C. Braden,et al.  National outbreak of Acanthamoeba keratitis associated with use of a contact lens solution, United States. , 2009, Emerging infectious diseases.

[25]  J. Sugar,et al.  Prognostic factors affecting visual outcome in Acanthamoeba keratitis. , 2008, Ophthalmology.

[26]  J. Niederkorn,et al.  Effect of immunization with the mannose-induced Acanthamoeba protein and Acanthamoeba plasminogen activator in mitigating Acanthamoeba keratitis. , 2007, Investigative ophthalmology & visual science.

[27]  Jong Soo Lee,et al.  Cysticidal Effect on Acanthamoeba and Toxicity on Human Keratocytes by Polyhexamethylene Biguanide and Chlorhexidine , 2007, Cornea.

[28]  H. Beele,et al.  Therapeutic Penetrating Keratoplasty: Clinical Outcome and Evolution of Endothelial Cell Density , 2002, Cornea.

[29]  C. Heney,et al.  Acanthamoeba keratitis with live isolates treated with cryosurgery and fluconazole. , 1999, American journal of ophthalmology.

[30]  D. Hodge,et al.  Ten-year postoperative results of penetrating keratoplasty. , 1998, Ophthalmology.

[31]  C. D. Illingworth,et al.  Acanthamoeba keratitis. , 1998, Survey of ophthalmology.

[32]  T. Lindquist,et al.  Treatment of Acanthamoeba Keratitist , 1998, Cornea.

[33]  W M Bourne,et al.  Central corneal endothelial cell changes over a ten-year period. , 1997, Investigative ophthalmology & visual science.

[34]  G. Stern,et al.  Diagnosis and successful medical treatment of Acanthamoeba keratitis. , 1995, Archives of ophthalmology.

[35]  W M Bourne,et al.  Corneal endothelium five years after transplantation. , 1994, American journal of ophthalmology.

[36]  G. Stern,et al.  Results of therapeutic penetrating keratoplasty. , 1993, Ophthalmology.

[37]  G. Visvesvara,et al.  The epidemiology of Acanthamoeba keratitis in the United States. , 1989, American journal of ophthalmology.

[38]  W. S. Head,et al.  Corneal toxicity of propamidine. , 1988, Archives of ophthalmology.

[39]  P. Wright,et al.  Acanthamoeba keratitis successfully treated medically. , 1985, The British journal of ophthalmology.

[40]  A. Steele,et al.  Amoebic infection of the eye. , 1974, Transactions of the ophthalmological societies of the United Kingdom.